Skip to main content
Contact Us
Subscribe
E-Edition
68°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Beam Therapeutics Inc
(NQ:
BEAM
)
21.60
-1.14 (-5.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Beam Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
The two clinical-stage gene-editing companies have good long-term prospects.
Via
The Motley Fool
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%
February 06, 2023
Cathie Wood is bullish about these stocks. And so are Wall Street analysts.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via
Benzinga
Analyst Ratings for Beam Therapeutics
February 01, 2023
Via
Benzinga
4 Analysts Have This to Say About Beam Therapeutics
December 20, 2022
Via
Benzinga
BMO Capital Upgrades Beam Therapeutics: Here's What You Need To Know
December 20, 2022
Via
Benzinga
Beam Therapeutics's Return On Capital Employed Insights
November 30, 2022
Via
Benzinga
Beam Therapeutics Temporarily Retreats Clinical Plans For Second Sickle Cell Gene Therapy
November 07, 2022
Via
Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve.
Via
InvestorPlace
5 Top Stocks for February
January 29, 2023
These growth stocks have more room to run.
Via
The Motley Fool
3 Great Growth Stocks Down 20% or More to Buy Now
January 27, 2023
These beaten-down stocks could be poised for major rebounds.
Via
The Motley Fool
A New Bull Market Is Coming: 3 Stocks That Could Skyrocket
January 21, 2023
Aggressive investors should check out these stocks.
Via
The Motley Fool
3 Stocks That Could Create Lasting Generational Wealth
January 15, 2023
Making money that spans generations requires thinking big.
Via
The Motley Fool
Why Beam Therapeutics Stock Is Falling Today
November 07, 2022
Beam's decision not to move forward with sickle cell treatment BEAM-102 isn't sitting well with investors today.
Via
The Motley Fool
Beam Therapeutics: Q3 Earnings Insights
November 07, 2022
Beam Therapeutics (NASDAQ:BEAM) reported its Q3 earnings results on Monday, November 7, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
January 04, 2023
Cathie Wood of ARK Investment Management believes U.S. equity markets are the polar opposite of what they were in the 90s when investors chased their dreams.
Via
Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2022
December 24, 2022
The attraction of all three biotech stocks is their potential.
Via
The Motley Fool
Analyst Beefs Up Beam Therapeutics Price Target, Says 'Reward Is Now Skewed To Upside'
December 20, 2022
Via
Benzinga
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
December 20, 2022
Wells Fargo raised Ross Stores, Inc. (NASDAQ: ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to close...
Via
Benzinga
7 ‘Next Big Things’ for Investors to Buy for 2023
December 13, 2022
The next big thing for investors in 2023 is buying companies with revenue expansion amid what could be a painful economic slowdown.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
Via
Benzinga
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
December 02, 2022
Although US stocks closed mixed on Thursday, but healthcare stocks recorded gains, gaining over 0.2% in the previous session. Biotechnology stocks were among the top performers in the sector, adding...
Via
Benzinga
A Sitcom Character Inspired This Investor
November 26, 2022
Plus, a look at the "Buffett premium" that investors give to Berkshire Hathaway stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
December 13, 2022
Via
Benzinga
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
November 14, 2022
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
TreeHouse Foods, Ritchie Bros. Auctioneers, Beam Therapeutics And Some Other Big Stocks Moving Lower On Monday
November 07, 2022
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Beam Therapeutics Stock Is Falling Today
November 07, 2022
Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading lower Monday after the company reported earnings results that were down year-over-year.
Via
Benzinga
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.